Posts Tagged ‘insomnia’
Should doctors prescribe Leqembi (lecanemab) to women with early Alzheimer’s Disease? The evidence-based answer is probably No
Welcome to a new edition of SharpBrains e‑newsletter, featuring this time a range of interventions for brain/ cognitive/ mental health plus a few brain teasers to test our perception and cognitive skills. #1. Should doctors prescribe lecanemab (Leqembi) to women? The answer, given available evidence, is probably No Huge (and mostly overlooked) red flag regarding newly…
Read MoreSmartphone-based cognitive behavioral therapy found to significantly decrease insomnia, substantially outperforming sleep education
Digital Therapy for Insomnia More Effective Than Sleep Education, Study Finds (American Journal of Managed Care): A smartphone-based, Chinese culture–adapted digital cognitive behavioral therapy for insomnia (DCBT‑I) application improved insomnia severity compared with sleep education, according to findings of a study published in JAMA Network Open. Researchers wanted to study the efficacy of this DCBT‑I app compared…
Read MoreAPA: With digital mental health going mainstream, will/ should psychologists be able to “prescribe” interventions?
Mental health, meet venture capital (APA): Until recently, mental health was a relative blip on the radar of venture capitalists. But over the past few years, and particularly since the onset of the COVID-19 pandemic, private investors have made a dramatic run for this space, pouring $3.1 billion into mental health ventures by the third…
Read MoreCould I be wrong? Exploring cognitive bias, curiosity, intellectual humility, and lifelong learning
Welcome to a new edition of SharpBrains’ e‑newsletter, featuring eight timely scientific and industry news plus a few fun teasers to appreciate our unique human brains. #1. Could I be wrong? Exploring research on cognitive bias, curiosity, intellectual humility, and lifelong learning “None of us thinks that our beliefs and attitudes are incorrect; if we…
Read MoreClick Therapeutics raises further $52M to build up digital therapeutics pipeline for depression, insomnia, smoking cessation and more
With Sanofi still on board, Click Therapeutics closes $52M series B for digital therapeutics in depression, chronic pain and more (Fierce Biotech): Another medtech developer’s plans to create digital therapeutics to treat a wide range of illnesses are clicking into place, thanks to a third multimillion-dollar investment in Click Therapeutics in barely a year.
Read MoreStudy: Self-guided sleep app Sleepio, combined with standard care for depression and anxiety, delivers better outcomes than standard care alone
Study backs benefit of insomnia DTx Sleepio on mental health (pharmaphorum): The study – published in the journal Behaviour Research and Therapy – tested the Sleepio app developed by digital health specialist Big Health as an add-on to standard NHS care for anxiety and depression under the improving access to psychological therapies (IAPT) policy. Patients…
Read More